Cetuximab (Erbitux)

American Journal of Neuroradiology - United States
doi 10.3174/ajnr.a2054
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Neuroradiology (ASNR)

Related search

Nutzen Der First-Line-Therapie Mit Cetuximab Bestätigt

Best Practice Onkologie
Oncology
2010English

Cetuximab Retreatment in Patients With Metastatic Colorectal Cancer Who Exhibited a Clinical Benefit in Response to Prior Cetuximab: A Retrospective Study

Oncology Letters
Cancer ResearchOncology
2018English

Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab

International Journal of Cancer
Cancer ResearchOncology
2019English

PTEN Status in Advanced Colorectal Cancer Treated With Cetuximab

British Journal of Cancer
Cancer ResearchOncology
2009English

Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab

International Journal of Cancer
Cancer ResearchOncology
2018English

Cetuximab Bei SCCHN: EXTREME — Keine Beeinträchtigung Der Lebensqualität

Info Onkologie
2010English

Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel in Vivo Model of Acquired Cetuximab Resistance

Clinical Cancer Research
Cancer ResearchOncology
2011English

Efficacy of Continued Cetuximab for Unresectable Metastatic Colorectal Cancer After Disease Progression During First-Line Cetuximab-Based Chemotherapy: A Retrospective Cohort Study

Oncotarget
Oncology
2016English

Nuclear EGFR Contributes to Acquired Resistance to Cetuximab

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy